ENDOTHELIUM-DEPENDENT CONTRACTIONS IN RABBIT PULMONARY-ARTERY ARE MEDIATED BY THROMBOXANE-A2

This study was designed to characterize the endothelium-dependent contracting factor (EDCF) released by arachidonic acid (AA) and methacholine (MeCH) in the rabbit pulmonary artery. AA and MeCH contract the rabbit pulmonary artery; however, the effects of both are blocked by denuding the vessels and by administration of indomethacin (a cyclooxygenase inhibitor), dazoxiben (a thromboxane [TX] synthase inhibitor), and SQ29548 (a TXA2/prostaglandin [PG] H-2 receptor antagonist). When segments of rabbit pulmonary artery were incubated with [C-14]AA and the [C-14] metabolites were resolved by reverse-phase high-performance liquid chromatography (HPLC), radioactive products were observed that comigrated with 6-keto-PGF1alpha and TXB2, the stable metabolites of prostacyclin and TXA2. The TXB2 radioactive peak was rechromatographed on normal-phase HPLC and again migrated with TXB2. Finally, the structures of derivatized [C-14]6-keto-PGF1alpha and [C-14]TXB2 peaks were confirmed by gas chromatography/mass spectrometry. The synthesis of [C-14]6-keto-PGF1alpha and [C-14]TXB2 was inhibited by removal of the endothelium and by indomethacin. Dazoxiben inhibited the synthesis of [C-14]TXB2 but not [C-14]6-keto-PGF1alpha. Using specific radioimmunoassays, AA and MeCH stimulated 6-keto-PGF1alpha and TXB2 release. Indomethacin blocked the production of both 6-keto-PGF1alpha and TXB2, whereas dazoxiben only blocked TXB2. In a superfusion[bioassay system, AA stimulated an endothelium-intact donor vessel to release a labile substance that contracted an indomethacin-treated endothelium-denuded recipient vessel. The EDCF released by AA had an approximate half-life of 30 seconds. Cultured rabbit pulmonary arterial endothelial cells synthesized 6-keto-PGF1alpha but not TXB2. Immunohistochemical studies indicated the presence of cyclooxygenase, but not TX synthase, in pulmonary artery endothelial cells. TXA2 appears to be the EDCF released by AA and MeCH in rabbit pulmonary artery; however, TXA2 is not produced by endothelial cells but may arise from cells that adhere to the luminal surfaces, such as platelets or macrophages.